RIZZI LAURA

Meanti, R., Criscione, M., Sartori, E., Rizzi, L., Bresciani, E., Mauri, M., et al. (2026). Anti-Inflammatory Effects of Progesterone on Human Microglia via TLR4/NLRP3 Pathway Modulation: Relevance to Drug-Resistant Epilepsy. PHARMACEUTICALS, 19(6) [10.3390/ph19060920]. Dettaglio

Bracchi, M., Rizzi, L., Russo, L. (2025). Extracellular matrix (ECM) and cellular features of a pediatric meniscus. Intervento presentato a: Pediatric meniscal injuries - TRANSALPINE CENTER OF PEDIATRIC SPORTS MEDICINE AND SURGERY 5TH CONFERENCE 07 febbraio 2025, Centro Congressi – IRCCS San Gerardo dei Tintori, Monza, Italy. Dettaglio

Meanti, R., Bresciani, E., Rizzi, L., Molteni, L., Coco, S., Omeljaniuk, R., et al. (2025). Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases. BIOMÉDECINE & PHARMACOTHÉRAPIE, 186(May 2025) [10.1016/j.biopha.2025.118044]. Dettaglio

Meanti, R., Rizzi, L., Bresciani, E., Licata, M., Molteni, L., Omeljaniuk, R., et al. (2024). Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells. Intervento presentato a: Innovazione e malattie rare: dalla ricerca preclinica al paziente, Bari, Italia. Dettaglio

Meanti, R., Rizzi, L., Bresciani, E., Licata, M., Molteni, L., Omeljaniuk, R., et al. (2024). Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study. Intervento presentato a: 9th European Congress of Pharmacology (EPHAR 2024), Atene, Grecia. Dettaglio